September 28, 2016
Breakthrough T1D Celebrates FDA Approval of Artificial Pancreas System
September 9, 2016
AnTolRx, Inc. Announces Series A Equity Funding from Pfizer, Breakthrough T1D and Orion Equity Partners, LLC to Develop Targeted Nanoparticle Tolerance Therapeutics
September 7, 2016
Breakthrough T1D and ISPAD Co-Sponsor Competitive Research Fellowship to Nurture Next Generation of Type 1 Diabetes Researchers
August 12, 2016
Breakthrough T1D Mourns the Passing of Dr. Aldo A. Rossini
August 12, 2016
Breakthrough T1D Announces Industry Development and Discovery Partnership with Pacific Diabetes Technologies
August 4, 2016
Breakthrough T1D and TrialReach Launch a New, No Cost Clinical Trial Matching Tool to Solve Critical Challenges in Diabetes Research
August 4, 2016
Unique New Book Series from Novo Nordisk and Breakthrough T1D Uses Customized Information by Age to Educate Children and Young Adults with Type 1 Diabetes
June 23, 2016
Selecta Biosciences Announces Pricing of Initial Public Offering
June 21, 2016
Carbylan Therapeutics to Merge with KalVista Pharmaceuticals
June 20, 2016
Breakthrough T1D Honors Type 1 Diabetes Research Champions
